Subscriber Only
Business
Prognosis
Trudeau’s Drug-Price Overhaul Is Set to Cost Drugmakers Billions
- Canada revamps drug-pricing regime for first time since 1987
- Cheaper medicines could potentially impact U.S. market as well

An employee works in the pharmacy drugstore in Toronto, Ontario, Canada.
Photographer: Cole Burston/Bloomberg